MRI-Linac

The MRI-Linac is state of the art cancer therapy equipment that will see an MRI coupled with a linear accelerator, to be pioneered in Australia at the Ingham Institute. One of only three in the world, the Ingham Institute will be the first medical research institute in Australia to acquire the unique technology that will be housed within the Research Bunker, a key feature of the Institute's new research precinct.

The group, led by Professor Paul Keall from the University of Sydney, is currently conducting a comprehensive research program to commission and develop a first-generation MRI-Linac. Achieving a significant milestone, the MRI-Linac group was awarded a $5.7 million program grant from the National Health and Medical Research Council (NHMRC) in December 2011, which resulted in a substantial contribution to infrastructure and research elements of the project.

The MRI-Linac has the ability to accurately locate tumours during a treatment session in real time, offering greater potential of improving patient cancer treatment outcomes. Once the MRI-Linac is operational it will set a new benchmark for cancer treatment in Australia, with the potential to dramatically reduce side effects and improve patient cancer treatment outcomes in over 50 per cent of all cancer patients.

Providing strong evidence for its efficacy, a study published in July 2011 by Prof Keall and collaborators in the international journal Medical Physics modelled key components of the MRI-Linac and supported the high-quality of the technology.

Group Leader:
Professor Paul Keall
View Profile

Group Leader:
Dr Gary Liney
View Profile